ClassID:

95252

C07D403/12 - page 17 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#4801
20130079347
2013-03-28

Sulfonylpyrroles

#4802
20130079345
2013-03-28

PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES

#4803
20130079339
2013-03-28

TRPV1 vanilloid receptor antagonists with a bicyclic portion

#4804
20130079338
2013-03-28

Selective NR2B antagonists

#4805
20130079328
2013-03-28

Substituted pyridines for modulating the WNT signaling pathway

#4806
20130079306
2013-03-28

Heterocyclic compound and p27degradation inhibitor

#4807
20130079302
2013-03-28

N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues

#4808
20130078213
2013-03-28

THROMBOPOIETIN MIMETICS

#4809
20130072496
2013-03-21

Formulations containing pyridazine compounds

#4810
20130072469
2013-03-21

Substituted 2,4-diaminopyrimidines as kinase inhibitors

#4811
20130072461
2013-03-21

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#4812
20130066069
2013-03-14

Processes for preparing substituted pyrimidines

#4813
20130065925
2013-03-14

Pyrrolidin-3-ylacetic acid derivative

#4814
20130065905
2013-03-14

Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine

#4815
20130065900
2013-03-14

Pharmaceutical compounds

#4816
20130065899
2013-03-14

2,4-disubstituted pyrimidines useful as kinase inhibitors

#4817
20130065892
2013-03-14

4,6-diaminopyrimidines useful as kinase inhibitors

#4818
20130065890
2013-03-14

Pyrimidine derivatives

#4819
20130065882
2013-03-14

VLA-4 inhibitory drug

#4820
20130065879
2013-03-14

Substituted 2,4-diaminopyrimidines as kinase inhibitors

#4821
20130065858
2013-03-14

Compounds useful as Raf kinase inhibitors

#4822
20130065325
2013-03-14

Zwitterionic reagents

#4823
20130064770
2013-03-14

RADIOLABELED COMPOUNDS AND METHODS THEREOF

#4824
20130059873
2013-03-07

Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)

#4825
20130059856
2013-03-07

Agonists of GPR131 and uses thereof

#4826
20130059852
2013-03-07

Compounds for treating disease, for administering, and for pharmaceutical compositions

#4827
20130059833
2013-03-07

PDE10 modulators

#4828
20130059829
2013-03-07

Treatment of central nervous system disorders

#4829
20130053577
2013-02-28

Antiviral compounds

#4830
20130053390
2013-02-28

1-[(6,7-substituted alkoxyquinoxalinyl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives for treating tumors

#4831
20130053386
2013-02-28

Diaryl ether derivatives as notch sparing gamma secretase inhibitors

#4832
20130053380
2013-02-28

Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease

#4833
20130053362
2013-02-28

Heterocyclic compounds and uses thereof

#4834
20130046004
2013-02-21

Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

#4835
20130045955
2013-02-21

Pyrimidline derivatives having immune modulating properties that act via TLR7 for the treatment of viral or allergic diseases and cancers

#4836
20130041149
2013-02-14

Method for synthesizing Imatinib

#4837
20130040977
2013-02-14

Pro-neurogenic compounds

#4838
20130040976
2013-02-14

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

#4839
20130040975
2013-02-14

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#4840
20130040964
2013-02-14

1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors

#4841
20130040963
2013-02-14

Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels

#4842
20130040951
2013-02-14

PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

#4843
20130040949
2013-02-14

Type II Raf kinase inhibitors

#4844
20130040944
2013-02-14

mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

#4845
20130040926
2013-02-14

Compound

#4846
20130035350
2013-02-07

Quinazoline derivatives

#4847
20130035342
2013-02-07

Compound suitable for the treatment of synucleopathies

#4848
20130034519
2013-02-07

Peptidomimetic sulfamide compounds and antiviral uses thereof

#4849
20130032788
2013-02-07

Carbazole-based compound and organic light-emitting diode comprising the same

#4850
20130030189
2013-01-31

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

#4851
20130030003
2013-01-31

9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof

#4852
20130029999
2013-01-31

Myosin light chain kinase inhibitor compounds, compositions and related methods of use

#4853
20130029994
2013-01-31

N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

#4854
20130029990
2013-01-31

PYRAZOLE P38 MAP KINASE INHIBITORS

#4855
20130029987
2013-01-31

Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith

#4856
20130029963
2013-01-31

1,2,4-triazine-4-amine derivatives

#4857
20130029962
2013-01-31

Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands

#4858
20130029942
2013-01-31

COMPOUNDS AND THERAPEUTICAL USES THEREOF

#4859
20130029939
2013-01-31

Glucokinase activators and methods of using same

#4860
20130025618
2013-01-31

Cationic 4-aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof

#4861
20130023576
2013-01-24

Pyrazole compounds as CRTH2 antagonists

#4862
20130023534
2013-01-24

PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

#4863
20130023532
2013-01-24

INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

#4864
20130023527
2013-01-24

1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia

#4865
20130023522
2013-01-24

Benzamides

#4866
20130023498
2013-01-24

MicroRNA Modulators and Method for Identifying and Using the Same

#4867
20130023497
2013-01-24

Triazine Derivatives and their Therapeutical Applications

#4868
20130022594
2013-01-24

Selective FAK inhibitors

#4869
20130022572
2013-01-24

Peptidomimetic sulfamide compounds and antiviral uses thereof

#4870
20130020559
2013-01-24

Organic electroluminescence device

#4871
20130019348
2013-01-17

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

#4872
20130018066
2013-01-17

Heterocyclic aspartyl protease inhibitors

#4873
20130018046
2013-01-17

Acetylenic heteroaryl compounds

#4874
20130018040
2013-01-17

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

#4875
20130018036
2013-01-17

Substituted indazole derivatives active as kinase inhibitors

#4876
20130018033
2013-01-17

RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF

#4877
20130017950
2013-01-17

5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals

#4878
20130017196
2013-01-17

Substituted imidazole derivates

#4879
20130012711
2013-01-10

Process for preparing 6-substituted-1-(2H)-isoquinolinones and intermediate compound

#4880
20130012708
2013-01-10

HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

#4881
20130012705
2013-01-10

Dicycloazaalkane derivatives, preparation processes and medical uses thereof

#4882
20130012704
2013-01-10

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

#4883
20130012557
2013-01-10

Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders

#4884
20130012543
2013-01-10

Cytoskeletal active rho kinase inhibitor compounds, composition and use

#4885
20130012529
2013-01-10

Heterobicyclic carboxamides as inhibitors for kinases

#4886
20130012523
2013-01-10

Pyrazinone derivatives, pharmaceutically acceptance salts thereof and their uses

#4887
20130012522
2013-01-10

Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases

#4888
20130012512
2013-01-10

P38 MAP kinase inhibitors

#4889
20130012500
2013-01-10

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

#4890
20130012493
2013-01-10

NOVEL SPIRO IMIDAZOLONE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

#4891
20130012476
2013-01-10

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

#4892
20130012434
2013-01-10

NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

#4893
20130012385
2013-01-10

Pesticides and uses thereof

#4894
20130012382
2013-01-10

Pyridazine compounds for controlling invertebrate pests

#4895
20130012381
2013-01-10

Pyridazine compounds for controlling invertebrate pests

#4896
20130012380
2013-01-10

Pyridazine compounds for controlling invertebrate pests

#4897
20130011923
2013-01-10

Modulators of ATP-binding cassette transporters

#4898
20130005965
2013-01-03

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#4899
20130005964
2013-01-03

Sulfonyl amide derivatives for the treatment of abnormal cell growth

#4900
20130005784
2013-01-03

CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES

#4901
20130005754
2013-01-03

Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use

#4902
20130005753
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4903
20130005751
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4904
20130005750
2013-01-03

Heterobicyclic carboxamides as inhibitors for kinases

#4905
20130005748
2013-01-03

Compounds and compositions as protein kinase inhibitors

#4906
20130005738
2013-01-03

Monocyclic Heteroaryl Compounds

#4907
20130005727
2013-01-03

QUINAZOLINE DERIVATIVES

#4908
20130005723
2013-01-03

Triazine compounds as PI3 kinase and mTOR inhibitors

#4909
20130005704
2013-01-03

SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS

#4910
20130005702
2013-01-03

Pyrazole derivatives as protein kinase modulators

#4911
20130004518
2013-01-03

Cyclic amine BACE-1 inhibitors having a benzamide substituent

#4912
20130001524
2013-01-03

Heterocyclic compound and organic light-emitting device comprising the same

#4913
20120330019
2012-12-27

Hepatitis C virus inhibitors

#4914
20120330015
2012-12-27

Process for the preparation of α-acyloxy β-formamido amides

#4915
20120329796
2012-12-27

COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN PARTICULAR PROGERIA

#4916
20120329784
2012-12-27

COMPOUNDS AND METHODS

#4917
20120329772
2012-12-27

Amino-tetrazoles analogues and methods of use

#4918
20120329771
2012-12-27

Benzylic oxindole pyrimidines

#4919
20120329704
2012-12-27

PROCESS FOR THE PREPARATION OF SUBSTITUTED PROLYL PEPTIDES AND SIMILAR PEPTIDOMIMETICS

#4920
20120322978
2012-12-20

CROSSLINKING REAGENTS, METHODS, AND COMPOSITIONS FOR STUDYING PROTEIN-PROTEIN INTERACTIONS

#4921
20120322826
2012-12-20

5-HT4 receptor agonists for the treatment of dementia

#4922
20120322795
2012-12-20

Biarylamide inhibitors of leukotriene production

#4923
20120316178
2012-12-13

Piperazines as antimalarial agents

#4924
20120316170
2012-12-13

Imidazole derivative

#4925
20120316153
2012-12-13

Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

#4926
20120316150
2012-12-13

AMIDE COMPOUNDS USEFUL IN THERAPY

#4927
20120316135
2012-12-13

Compounds for inhibiting cell proliferation in EGFR-driven cancers

#4928
20120309791
2012-12-06

Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins

#4929
20120309777
2012-12-06

Substituted 2-imidazolidones and analogs

#4930
20120309769
2012-12-06

N-benzylindole modulators of PPARG

#4931
20120309766
2012-12-06

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

#4932
20120309759
2012-12-06

Screening method and compounds for modulating telomerase activity

#4933
20120309757
2012-12-06

N-biphenylmethylindole modulators of PPARG

#4934
20120309741
2012-12-06

Quinoxaline carboxamide derivatives as protein tyrosine kinase inhibitors

#4935
20120309738
2012-12-06

Compounds

#4936
20120309736
2012-12-06

Cyclic benzimidazole derivatives useful as anti-diabetic agents

#4937
20120308587
2012-12-06

Neprilysin inhibitors

#4938
20120302761
2012-11-29

Intermediates useful in the preparation of maleimide functionalized polymers

#4939
20120302751
2012-11-29

Carbazole derivative with heteroaromatic ring, and light-emitting element, light-emitting device, and electronic device using carbazole derivative with heteroaromatic ring

#4940
20120302750
2012-11-29

Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors

#4941
20120302617
2012-11-29

Phenyl and benzodioxinyl substituted indazoles derivatives

#4942
20120302545
2012-11-29

Method of using PI3K and MEK modulators

#4943
20120301974
2012-11-29

Clozapine immunoassay

#4944
20120301973
2012-11-29

CLOZAPINE IMMUNOASSAY

#4945
20120301427
2012-11-29

Chemokine receptor binding heterocyclic compounds with enhanced efficacy

#4946
20120295938
2012-11-22

Ethers, secondary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#4947
20120295911
2012-11-22

Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases

#4948
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

#4949
20120295901
2012-11-22

Substituted bicyclic triazole derivatives as gamma secretase modulators

#4950
20120295891
2012-11-22

Substituted triazole derivatives as gamma secretase modulators

#4951
20120295884
2012-11-22

Complement pathway modulators and uses thereof

#4952
20120295881
2012-11-22

Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy

#4953
20120289709
2012-11-15

Substantially Stereomerically Pure Fused Bicyclic Proline Compounds and Processes for Preparing Boceprevir

#4954
20120289511
2012-11-15

Compositions and methods for treating alzheimer's disease

#4955
20120289507
2012-11-15

Pyridazinyl derivatives as smo inhibitors

#4956
20120289505
2012-11-15

Inhibitors of diacylglycerol acyl transferase

#4957
20120289493
2012-11-15

Fused heterocyclic compounds as ion channel modulators

#4958
20120288871
2012-11-15

Modified carbocyanine dyes and their conjugates

#4959
20120283287
2012-11-08

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS

#4960
20120283273
2012-11-08

Indole and azaindole modulators of the alpha 7 nachr

#4961
20120283271
2012-11-08

Isoindolinone derivatives

#4962
20120283265
2012-11-08

Compounds useful for treating AIDS

#4963
20120283261
2012-11-08

Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase

#4964
20120283194
2012-11-08

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#4965
20120277277
2012-11-01

Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal

#4966
20120277258
2012-11-01

Chemical Compounds

#4967
20120277244
2012-11-01

PYRAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS

#4968
20120277232
2012-11-01

Pyridine and pyrazine derivative for the treatment of CF

#4969
20120277230
2012-11-01

COMPOUNDS USEFUL FOR TREATING CANCER

#4970
20120277217
2012-11-01

Imidazole derivatives as IDO inhibitors

#4971
20120277209
2012-11-01

PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS

#4972
20120277208
2012-11-01

BENZAMIDE COMPOUND

#4973
20120277207
2012-11-01

Heterocyclic acrylamides and their use as pharmaceuticals

#4974
20120277205
2012-11-01

Derivatives of N-[(1-pyrazol-1-yl)aryl]-1-indole or 1-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics

#4975
20120277190
2012-11-01

PRODRUGS OF COMPOUNDS THAT INHIBIT TRPV1 RECEPTOR

#4976
20120272461
2012-11-01

Dyes with changeable solubilities, and methods for their use

#4977
20120270889
2012-10-25

Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use

#4978
20120270875
2012-10-25

PYRIMIDINE AMIDE COMPOUNDS

#4979
20120270873
2012-10-25

Adamantyl diamide derivatives and uses of same

#4980
20120270867
2012-10-25

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

#4981
20120270863
2012-10-25

FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS

#4982
20120270861
2012-10-25

Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

#4983
20120270859
2012-10-25

INDOLINE DERIVATIVES AND THEIR USE IN TREATING DISEASE-STATES SUCH AS CANCER

#4984
20120270858
2012-10-25

Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling

#4985
20120270853
2012-10-25

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors

#4986
20120270318
2012-10-25

Ion channel modulators and methods of use

#4987
20120269766
2012-10-25

Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus

#4988
20120264801
2012-10-18

5-membered heterocycle-based P38 kinase inhibitors

#4989
20120264761
2012-10-18

Aminobenzoquinazolinone M1 receptor positive allosteric modulators

#4990
20120264759
2012-10-18

Benzyl substituted triazine derivatives and their therapeutical applications

#4991
20120264754
2012-10-18

Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

#4992
20120264728
2012-10-18

Amino-heteroaryl derivatives as HCN blockers

#4993
20120259111
2012-10-11

Seven-membered ring compound and pharmaceutical use therefor

#4994
20120258963
2012-10-11

Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists

#4995
20120258946
2012-10-11

Substituted phenylureas and phenylamides as vanilloid receptor ligands

#4996
20120253039
2012-10-04

Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds

#4997
20120252818
2012-10-04

Substituted pyrimidine compounds and uses thereof

#4998
20120252790
2012-10-04

Amino-derivatives as novel inhibitors of histone deacetylase

#4999
20120252770
2012-10-04

Chemical Compounds 572

#5000
20120245187
2012-09-27

Heterobicyclic carboxamides as inhibitors for kinases

#5001
20120245172
2012-09-27

Heterocyclic amine derivatives

#5002
20120245139
2012-09-27

Inhibitors of the hedgehog pathway

#5003
20120245125
2012-09-27

Pyridazine compounds, compositions and methods

#5004
20120244581
2012-09-27

Biocatalytic processes for the preparation of stereomerically pure fused bicyclic proline compounds

#5005
20120238676
2012-09-20

Use of oligomeric carbodiimides as stabilizers

#5006
20120238578
2012-09-20

Compositions useful as inhibitors of voltage-gated sodium channels

#5007
20120238570
2012-09-20

Inhibitors of the hedgehog pathway

#5008
20120238551
2012-09-20

Substituted phenoxypropylcycloamine derivatives as histamine-3 (H) receptor ligands

#5009
20120238550
2012-09-20

Compound

#5010
20120238540
2012-09-20

AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1

#5011
20120238539
2012-09-20

Piperazine analogs as broad-spectrum influenza antivirals

#5012
20120236598
2012-09-20

Edge-illuminated flat panel and light module for same

#5013
20120232268
2012-09-13

Dipeptide mimics, libraries combining two dipeptide mimics with a third group, and methods for production thereof

#5014
20120232113
2012-09-13

Methods of treating emesis using growth hormone secretagogues

#5015
20120232101
2012-09-13

Novel Compounds

#5016
20120232093
2012-09-13

PYRAZOLE DERIVATIVES AS SIGMA RECEPTOR INHIBITORS

#5017
20120232092
2012-09-13

Heterocyclic sulfonamides

#5018
20120232084
2012-09-13

Pyrrolidin-3yl-methylamine quinoxaline derivatives

#5019
20120232078
2012-09-13

Medicaments

#5020
20120232071
2012-09-13

2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds

#5021
20120232070
2012-09-13

Use of Indole Derivatives as Nurr-1 Activators for the Application Thereof as a Medicament for the Treatment of Parkinson's Disease

#5022
20120232068
2012-09-13

Quinazolines as potassium ion channel inhibitors

#5023
20120232061
2012-09-13

Compounds

#5024
20120232055
2012-09-13

Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors

#5025
20120232049
2012-09-13

PYRIDINE OR PYRIMIDINE DERIVATIVE HAVING EXCELLENT CELL GROWTH INHIBITION EFFECT AND EXCELLENT ANTI-TUMOR EFFECT ON CELL STRAIN HAVING AMPLIFICATION OF HGFR GENE

#5026
20120232028
2012-09-13

Bicyclic compound, production and use thereof

#5027
20120231998
2012-09-13

Organic compounds and their uses

#5028
20120230984
2012-09-13

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

#5029
20120226033
2012-09-06

4-alkoxy-N-(2-hydroxycarbamoyl-2-piperidinyl-ethyl)-benzamide compounds as selective TACE-inhibitors for the treatment of inflammatory diseases

#5030
20120225910
2012-09-06

(S)-6-(2-(4-(cyclobutylsulfonyl)-1H-imidazol-1-yl)-3-cyclopentylpropanamido)nicotinic acid useful as a glucokinase activator

#5031
20120225909
2012-09-06

INDAZOLE ANALOG

#5032
20120225887
2012-09-06

Glucokinase Activators

#5033
20120225886
2012-09-06

Pyrrolidine derived beta 3 adrenergic receptor agonists

#5034
20120225880
2012-09-06

Pyrazole compounds and thiazole compounds as protein kinases inhibitors

#5035
20120225878
2012-09-06

COMPOUNDS

#5036
20120225872
2012-09-06

Methods of preparing and using quinazoline and quinoline derivatives

#5037
20120225867
2012-09-06

Androgen receptor modulating compounds

#5038
20120225866
2012-09-06

Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation

#5039
20120225809
2012-09-06

Compounds for treating papilloma virus infection

#5040
20120223276
2012-09-06

Materials for electronic devices

#5041
20120220588
2012-08-30

Quinazoline compounds

#5042
20120220584
2012-08-30

Heterocyclic compounds and methods of use

#5043
20120220537
2012-08-30

9-AMINOACRIDINE DERIVATIVES, THEIR PREPARATION AND USES

#5044
20120217449
2012-08-30

MATERIALS FOR ELECTRONIC DEVICES

#5045
20120214822
2012-08-23

N-cyclopropyl-3-fluoro-5-[3-[[1-[2-[2- [(2-hydroxethyl)amino] ethoxy]phenyl] cyclopropyl] amino]-2-oxo-1 (2H)-pyrazinyl]-4-methyl-benzamide, or pharmaceutically acceptable salts thereof and their uses

#5046
20120214817
2012-08-23

Urotensin II receptor antagonists

#5047
20120214809
2012-08-23

Aminoindane compounds and use thereof in treating pain

#5048
20120214801
2012-08-23

COMPOSITIONS AND METHODS RELATING TO NOVEL COMPOUNDS AND TARGETS THEREOF

#5049
20120214789
2012-08-23

Tetrazole-substituted arylamides as P2Xand P2Xantagonists

#5050
20120214786
2012-08-23

3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents

#5051
20120214766
2012-08-23

Cannabinoid receptor modulators

#5052
20120213806
2012-08-23

Neprilysin inhibitors

#5053
20120213795
2012-08-23

Compositions and methods for inhibition of the JAK pathway

#5054
20120213791
2012-08-23

3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators

#5055
20120213729
2012-08-23

Compounds for the treatment of hepatitis C

#5056
20120208852
2012-08-16

Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof

#5057
20120208823
2012-08-16

Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists

#5058
20120208821
2012-08-16

Alpha adrenergic receptor modulators

#5059
20120208819
2012-08-16

Heterocyclic compounds useful as PDK1 inhibitors

#5060
20120208803
2012-08-16

Pyrrolidine derivatives as NK2 receptor antagonists

#5061
20120207769
2012-08-16

Inhibitors of IAP

#5062
20120207765
2012-08-16

Chemokine receptor antagonists and use thereof

#5063
20120202834
2012-08-09

Glucagon receptor modulators

#5064
20120202818
2012-08-09

UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS

#5065
20120202816
2012-08-09

Pyrazole-based thyroid receptor compounds

#5066
20120202814
2012-08-09

COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF

#5067
20120202813
2012-08-09

Triazole compounds that modulate HSP90 activity

#5068
20120202785
2012-08-09

Heterocyclic compounds and methods of use

#5069
20120202756
2012-08-09

USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS

#5070
20120202750
2012-08-09

Inhibitors of IAP

#5071
20120202687
2012-08-09

Pesticidal compositions and processes related thereto

#5072
20120201816
2012-08-09

Lactam-containing compounds and derivatives thereof as factor XA inhibitors

#5073
20120197027
2012-08-02

Quinazoline derivatives as angiogenesis inhibitors

#5074
20120197019
2012-08-02

COMPOSITIONS AND PROCESSES

#5075
20120197013
2012-08-02

SIRTUIN MODULATING COMPOUNDS

#5076
20120196908
2012-08-02

Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same

#5077
20120196897
2012-08-02

NEW COMPOUNDS

#5078
20120196885
2012-08-02

Histone deacetylase inhibitors based simultaneously on trisubstituted 1-pyrroles and aromatic and heteroaromatic spacers

#5079
20120196864
2012-08-02

PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER

#5080
20120196860
2012-08-02

Triazine derivatives and their therapeutical applications

#5081
20120196851
2012-08-02

Wnt pathway antagonists

#5082
20120196824
2012-08-02

THERAPEUTIC AGENT FOR CEREBRAL INFARCTION

#5083
20120190866
2012-07-26

Antiviral compounds

#5084
20120190864
2012-07-26

Process for preparation of high molecular weight molybdenum succinimide complexes

#5085
20120190845
2012-07-26

Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor

#5086
20120190688
2012-07-26

APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES

#5087
20120190686
2012-07-26

Bicyclo[3.2.1]octyl amide derivatives and uses of same

#5088
20120190685
2012-07-26

Phenylimidazole derivative as PDE10A enzyme inhibitor

#5089
20120190682
2012-07-26

Modulators for amyloid beta

#5090
20120190614
2012-07-26

HCV protease inhibitors and uses thereof

#5091
20120190543
2012-07-26

Pesticidal compositions

#5092
20120189539
2012-07-26

Bcl-2/Bcl-xL inhibitors and therapeutic methods using the same

#5093
20120184561
2012-07-19

PHENYLACETAMIDES SUITABLE AS PROTEIN KINASE INHIBITORS

#5094
20120184553
2012-07-19

Compounds

#5095
20120184535
2012-07-19

Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent

#5096
20120184530
2012-07-19

Dimeric IAP Inhibitors

#5097
20120184523
2012-07-19

C-Met Modulators and Method of Use

#5098
20120184520
2012-07-19

Glycine compound

#5099
20120183974
2012-07-19

Screening method for enzyme inhibitors

#5100
20120183563
2012-07-19

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions and their use